| Integrity Staffing Solutions | 65.2 | 2 | 2 |
| Aerotek | 65.2 | 2 | 2 |
| Staffmark | 65.2 | 2 | 2 |
| ResourceMFG | 65.2 | 2 | 2 |
| Peoplelink Staffing Solutions | 65.2 | 2 | 2 |
| Automatic Data Processing | 60.0 | 3 | 0 |
| Alpha Tomo Global Resoures Sdn Bhd | 60.0 | 3 | 0 |
| Arthur J. Gallagher & Co. | 60.0 | 3 | 0 |
| AppleOne | 58.7 | 2 | 1 |
| ProLogistix | 58.7 | 2 | 1 |
| ManpowerGroup | 58.7 | 2 | 1 |
| Randstad N.V. | 47.5 | 2 | 0 |
| Kelly Services | 47.5 | 2 | 0 |
| Robert Half | 47.5 | 2 | 0 |
| Gallagher | 47.5 | 2 | 0 |
| Jordan/Zalaznick Advisers Inc. | 47.5 | 2 | 0 |
| Adecco Staffing, Germany | 41.2 | 1 | 1 |
| SnagAJob.com | 41.2 | 1 | 1 |
| @WORK | 41.2 | 1 | 1 |
| PeopleReady | 41.2 | 1 | 1 |
| Labor Finders | 41.2 | 1 | 1 |
| HireQuest | 41.2 | 1 | 1 |
| PRIDESTAFF | 41.2 | 1 | 1 |
| Select Staffing | 41.2 | 1 | 1 |
| SThree | 40.0 | 0 | 11 |
| People | 30.0 | 1 | 0 |
| IQVIA Holdings, Inc. | 30.0 | 1 | 0 |
| Accenture | 30.0 | 1 | 0 |
| The Adecco Group | 30.0 | 1 | 0 |
| Aspen Institute | 30.0 | 1 | 0 |
| CareerBuilder | 30.0 | 1 | 0 |
| Indeed | 30.0 | 1 | 0 |
| CDC Group | 30.0 | 1 | 0 |
| Morningstar, Inc. | 30.0 | 1 | 0 |
| IQVIA | 30.0 | 1 | 0 |
| Toll Group | 30.0 | 1 | 0 |
| Korn Ferry | 30.0 | 1 | 0 |
| Toll NZ | 30.0 | 1 | 0 |
| Academy Sports + Outdoors | 30.0 | 1 | 0 |
| Allegis Group | 30.0 | 1 | 0 |
| Aspen Network of Development Entrepreneurs | 30.0 | 1 | 0 |
| Aspen Strategy Group | 30.0 | 1 | 0 |
| Kforce | 30.0 | 1 | 0 |
| Simply Hired | 30.0 | 1 | 0 |
| TriNet HR Services | 30.0 | 1 | 0 |
| ZipRecruiter | 30.0 | 1 | 0 |
| Accenture Technology Solutions Japan | 30.0 | 1 | 0 |
| Toll Domestic Forwarding | 30.0 | 1 | 0 |
| Insperity | 30.0 | 1 | 0 |
| Heidrick & Struggles | 30.0 | 1 | 0 |
| Zalaris | 30.0 | 1 | 0 |
| Elwood Staffing | 30.0 | 1 | 0 |
| Cornerstone OnDemand Inc. | 30.0 | 1 | 0 |
| Quess Corp | 30.0 | 1 | 0 |
| Jobvite | 30.0 | 1 | 0 |
| Adecco Staffing, USA | 30.0 | 1 | 0 |
| Accenture (Spain) | 30.0 | 1 | 0 |
| Accenture (United States) | 30.0 | 1 | 0 |
| Accenture (Norway) | 30.0 | 1 | 0 |
| Accenture (United Kingdom) | 30.0 | 1 | 0 |
| Accenture (Switzerland) | 30.0 | 1 | 0 |
| Accenture (Sweden) | 30.0 | 1 | 0 |
| TrueBlue | 30.0 | 1 | 0 |
| temporary work agency | 28.8 | 0 | 5 |
| employment agency | 22.3 | 0 | 3 |
| Gi Group | 17.7 | 0 | 2 |
| Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox–Gastaut Syndrome | 17.7 | 0 | 2 |
| Retention rates of levetiraceram in Chinese children and adolescents with epilepsy | 17.7 | 0 | 2 |
| Artech | 17.7 | 0 | 2 |
| Managing temporary staffing services: selecting the right agency | 17.7 | 0 | 2 |
| Contract staffing firms: replacing the dentist as the employer | 17.7 | 0 | 2 |
| Largest travel nurse staffing firms in the U.S. Ranked by estimated 2008 U.S. temporary staffing revenue | 17.7 | 0 | 2 |
| Largest per diem nurse staffing firms in the U.S. Ranked by estimated 2008 U.S. temporary staffing revenue | 17.7 | 0 | 2 |
| By the numbers. Largest travel nurse staffing firms in the U.S. Ranked by estimated 2009 U.S. temporary staffing revenue ($ millions) | 17.7 | 0 | 2 |
| By the numbers. Largest per diem nurse staffing firms in the U.S. Ranked by estimated 2009 U.S. temporary staffing revenue ($ millions) | 17.7 | 0 | 2 |
| By the number. Largest U.S. travel nurse staffing firms. Ranked by estimated 2010 U.S. temporary staffing revenue ($ millions) | 17.7 | 0 | 2 |
| By the number. Largest U.S. per diem nurse staffing firms. Ranked by estimated 2010 U.S. temporary staffing revenue ($ millions) | 17.7 | 0 | 2 |
| By the number. Largest U.S. locum tenens staffing firms. Ranked by estimated 2010 U.S. temporary staffing revenue ($ millions) | 17.7 | 0 | 2 |
| Largest U.S. travel nursing staffing firms. Ranked by estimated 2014 U.S. temporary staffing revenue ($ in millions) | 17.7 | 0 | 2 |
| Largest U.S. travel nurse staffing firms: Ranked by estimated 2015 U.S. temporary staffing revenue ($ in millions) | 17.7 | 0 | 2 |
| Largest U.S. travel nurse staffing firms. Ranked by estimated 2012 U.S. temporary staffing revenue ($ in millions) | 17.7 | 0 | 2 |
| Largest U.S. travel nurse staffing firms ranked by estimated 2013 U.S. temporary staffing revenue ($ in millions) | 17.7 | 0 | 2 |
| The triangular working arrangement : a qualitative study of the relationship between Auckland temporary staffing agencies, their client organisations and temporary clerical workers | 17.7 | 0 | 2 |
| TIGI HR | 17.7 | 0 | 2 |
| Placing Visually Impaired Clients through Temporary Employment Agencies and Staffing Agencies | 17.7 | 0 | 2 |
| Ultimate Staffing Services | 17.7 | 0 | 2 |
| staffing service | 17.7 | 0 | 2 |
| Abez Investment Pvt Ltd | 17.7 | 0 | 2 |
| Temporary Solutions | 17.7 | 0 | 2 |
| Uptalen | 17.7 | 0 | 2 |
| RSA Recruitment Space Agency | 17.7 | 0 | 2 |
| security clearance | 11.2 | 0 | 1 |
| Academic Work | 11.2 | 0 | 1 |
| Amadeus FiRe AG | 11.2 | 0 | 1 |
| Andreas Feininger | 11.2 | 0 | 1 |
| job centre | 11.2 | 0 | 1 |
| ASTON CARTER | 11.2 | 0 | 1 |
| recruitment | 11.2 | 0 | 1 |
| transport network | 11.2 | 0 | 1 |
| DIS AG | 11.2 | 0 | 1 |
| spree killer | 11.2 | 0 | 1 |
| automatic lubrication system | 11.2 | 0 | 1 |
| Q1361520 | 11.2 | 0 | 1 |
| fillrate | 11.2 | 0 | 1 |
| IT-Systemhaus Federal Employment Agency of Germany | 11.2 | 0 | 1 |
| German classification of occupations 2010 | 11.2 | 0 | 1 |
| Classification of professions in Germany | 11.2 | 0 | 1 |
| recruiter | 11.2 | 0 | 1 |
| Occupational Psychology Service of the Federal Employment Agency | 11.2 | 0 | 1 |
| Gagosian Gallery | 11.2 | 0 | 1 |
| Orizon | 11.2 | 0 | 1 |
| National Employment Agency | 11.2 | 0 | 1 |
| umbrella company | 11.2 | 0 | 1 |
| Centre for Addiction and Mental Health | 11.2 | 0 | 1 |
| Swedish Defence Recruitment Agency | 11.2 | 0 | 1 |
| recruitment process outsourcing | 11.2 | 0 | 1 |
| Synergie Group | 11.2 | 0 | 1 |
| Altarpiece of the Saints John | 11.2 | 0 | 1 |
| National Vocational Qualification | 11.2 | 0 | 1 |
| 40Plus | 11.2 | 0 | 1 |
| Luba Group | 11.2 | 0 | 1 |
| Bangladesh Association of International Recruiting Agencies | 11.2 | 0 | 1 |
| Blue Arrow | 11.2 | 0 | 1 |
| Brady Handgun Violence Prevention Act | 11.2 | 0 | 1 |
| Breathe City Church | 11.2 | 0 | 1 |
| Hello Work | 11.2 | 0 | 1 |
| Carlisle Managed Solutions | 11.2 | 0 | 1 |
| Cleary University | 11.2 | 0 | 1 |
| Commonwealth Employment Service | 11.2 | 0 | 1 |
| Contingent workforce | 11.2 | 0 | 1 |
| Employment Act 2008 | 11.2 | 0 | 1 |
| Employment Agencies Act 1973 | 11.2 | 0 | 1 |
| Employment Agency Standards Inspectorate | 11.2 | 0 | 1 |
| Employment Protection Act 1975 | 11.2 | 0 | 1 |
| Employment Relations Act 1999 | 11.2 | 0 | 1 |
| English Language Skills Assessment | 11.2 | 0 | 1 |
| Federal Public Service Commission | 11.2 | 0 | 1 |
| Fee-Charging Employment Agencies Convention, 1933 | 11.2 | 0 | 1 |
| Fee-Charging Employment Agencies Convention (Revised), 1949 | 11.2 | 0 | 1 |
| Fill rate | 11.2 | 0 | 1 |
| HAMK Häme University of Applied Sciences | 11.2 | 0 | 1 |
| Bizkaia:xede | 11.2 | 0 | 1 |
| Turkish Labor Agency | 11.2 | 0 | 1 |
| Nurse registry | 11.2 | 0 | 1 |
| Pasona | 11.2 | 0 | 1 |
| permatemp | 11.2 | 0 | 1 |
| Private Employment Agencies Convention, 1997 | 11.2 | 0 | 1 |
| Reed | 11.2 | 0 | 1 |
| retention rate | 11.2 | 0 | 1 |
| Robert Walters plc | 11.2 | 0 | 1 |
| Scantec | 11.2 | 0 | 1 |
| simultaneous editing | 11.2 | 0 | 1 |
| Talascend | 11.2 | 0 | 1 |
| Taleo | 11.2 | 0 | 1 |
| Talx | 11.2 | 0 | 1 |
| Thinking Skills Assessment | 11.2 | 0 | 1 |
| United Kingdom agency worker law | 11.2 | 0 | 1 |
| vendor management system | 11.2 | 0 | 1 |
| Westaff | 11.2 | 0 | 1 |
| Category:Employment agencies | 11.2 | 0 | 1 |
| Category:Employment agencies by country | 11.2 | 0 | 1 |
| Category:Employment agencies of the United Kingdom | 11.2 | 0 | 1 |
| Category:Employment agencies of the Netherlands | 11.2 | 0 | 1 |
| Category:Temporary employment agencies | 11.2 | 0 | 1 |
| Category:Employment agencies of Japan | 11.2 | 0 | 1 |
| drug screening | 11.2 | 0 | 1 |
| Lernia | 11.2 | 0 | 1 |
| private employment agency | 11.2 | 0 | 1 |
| Employment Ordinance | 11.2 | 0 | 1 |
| NX Careerroad | 11.2 | 0 | 1 |
| Digitalscape | 11.2 | 0 | 1 |
| Fullcast Co., Ltd. | 11.2 | 0 | 1 |
| Employment Agency | 11.2 | 0 | 1 |
| Korea Employment Agency for Persons with Disabilities | 11.2 | 0 | 1 |
| Category:Employment agencies of the United States | 11.2 | 0 | 1 |
| Category:Employment agencies of Australia | 11.2 | 0 | 1 |
| Category:Employment agencies of Canada | 11.2 | 0 | 1 |
| Category:Employment agencies of France | 11.2 | 0 | 1 |
| Category:Employment agencies of Hong Kong | 11.2 | 0 | 1 |
| Category:Employment agencies of India | 11.2 | 0 | 1 |
| Category:Employment agencies of Singapore | 11.2 | 0 | 1 |
| Category:Employment agencies of Sweden | 11.2 | 0 | 1 |
| Azerbaijan Public Employment Agency | 11.2 | 0 | 1 |
| recruitment agency | 11.2 | 0 | 1 |
| Gun background checks a no-go in US Senate | 11.2 | 0 | 1 |
| IQ Analytics | 11.2 | 0 | 1 |
| Sindh Public Service Commission | 11.2 | 0 | 1 |
| The Conduct of Employment Agencies and Employment Businesses Regulations 2003 | 11.2 | 0 | 1 |
| Order Fill Rate | 11.2 | 0 | 1 |
| Margery Hurst | 11.2 | 0 | 1 |
| Background Checks for Firearm Transfers | 11.2 | 0 | 1 |
| Criminal History Background Checks Pilot Extension Act of 2008 | 11.2 | 0 | 1 |
| Criminal History Background Checks Pilot Extension Act of 2008 | 11.2 | 0 | 1 |
| Criminal History Background Checks Pilot Extension Act of 2008 | 11.2 | 0 | 1 |
| Criminal History Background Checks Pilot Extension Act of 2009 | 11.2 | 0 | 1 |
| Integrity Staffing Solutions, Inc. v. Busk | 11.2 | 0 | 1 |
| Team Health Holdings | 11.2 | 0 | 1 |
| Zoo U: A Stealth Approach to Social Skills Assessment in Schools | 11.2 | 0 | 1 |
| Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin Z | 11.2 | 0 | 1 |
| universal background check | 11.2 | 0 | 1 |
| Pareto | 11.2 | 0 | 1 |
| Maine background checks referendum, 2016 | 11.2 | 0 | 1 |
| Work-related injuries in a state trauma registry: relationship between industry and drug screening | 11.2 | 0 | 1 |
| Proman | 11.2 | 0 | 1 |
| Alcohol and drug screening of occupational drivers for preventing work-related injury | 11.2 | 0 | 1 |
| Alcohol and drug screening of occupational drivers for preventing injury | 11.2 | 0 | 1 |
| Alcohol and drug screening of occupational drivers for preventing injury | 11.2 | 0 | 1 |
| Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts | 11.2 | 0 | 1 |
| September 2011 Kabul attack | 11.2 | 0 | 1 |
| MeritHall Inc | 11.2 | 0 | 1 |
| Simultaneous communication of study results to workers and management at multiple locations | 11.2 | 0 | 1 |
| Employment agency | 11.2 | 0 | 1 |
| Manpower Employment Agency | 11.2 | 0 | 1 |
| Computer model simulates screening process under variety of conditions. Semi-empirical approach allows researchers more latitude. Part I | 11.2 | 0 | 1 |
| Computer model simulates screening process under variety of conditions. Semi-empirical approach allows researchers more latitude. Part II | 11.2 | 0 | 1 |
| Laser Irradiation as a Rapid Screening Process for the Evaluation of Flame Inhibitors | 11.2 | 0 | 1 |
| Chapman, Jewellers Jean Set Jobfinders Employment Agency | 11.2 | 0 | 1 |
| Re-Use of Established Drugs for Anti-Metastatic Indications | 11.2 | 0 | 1 |
| Fluorescence anisotropy (polarization): from drug screening to precision medicine | 11.2 | 0 | 1 |
| Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening | 11.2 | 0 | 1 |
| Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening | 11.2 | 0 | 1 |
| Recent applications of chemosensitivity tests for colorectal cancer treatment | 11.2 | 0 | 1 |
| Trends in protein-based biosensor assemblies for drug screening and pharmaceutical kinetic studies | 11.2 | 0 | 1 |
| Induced pluripotent stem cells as a disease modeling and drug screening platform | 11.2 | 0 | 1 |
| Neural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrix | 11.2 | 0 | 1 |
| Cellular Biomechanics in Drug Screening and Evaluation: Mechanopharmacology | 11.2 | 0 | 1 |
| Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era | 11.2 | 0 | 1 |
| UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. | 11.2 | 0 | 1 |
| A Recombinant Human Pluripotent Stem Cell Line Stably Expressing Halide-Sensitive YFP-I152L for GABAAR and GlyR-Targeted High-Throughput Drug Screening and Toxicity Testing | 11.2 | 0 | 1 |
| High-throughput analysis of behavior for drug discovery | 11.2 | 0 | 1 |
| Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids | 11.2 | 0 | 1 |
| Engineering a Brain Cancer Chip for High-throughput Drug Screening | 11.2 | 0 | 1 |
| High Throughput Ratio Imaging to Profile Caspase Activity: Potential Application in Multiparameter High Content Apoptosis Analysis and Drug Screening | 11.2 | 0 | 1 |
| Drug screening: zebrafish as a tool for studying epileptic-related chemical compounds | 11.2 | 0 | 1 |
| Human Vascular Microphysiological System for in vitro Drug Screening | 11.2 | 0 | 1 |
| Assay development and high-throughput antiviral drug screening against Bluetongue virus | 11.2 | 0 | 1 |
| The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus | 11.2 | 0 | 1 |
| Variety Show Employment Agency | 11.2 | 0 | 1 |
| Workers' compensation filings of temporary workers compared to direct hire workers in Illinois, 2007-2012 | 11.2 | 0 | 1 |
| Adecco General Staffing, New Zealand | 11.2 | 0 | 1 |
| A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening | 11.2 | 0 | 1 |
| Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening | 11.2 | 0 | 1 |
| Obesity among health service providers in Nigeria: danger to long term health worker retention? | 11.2 | 0 | 1 |
| Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test | 11.2 | 0 | 1 |
| Globsec | 11.2 | 0 | 1 |
| Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds | 11.2 | 0 | 1 |
| Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening | 11.2 | 0 | 1 |
| A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility | 11.2 | 0 | 1 |
| TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico | 11.2 | 0 | 1 |
| Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease | 11.2 | 0 | 1 |
| A Drug Screening Method Based on the Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus | 11.2 | 0 | 1 |
| Introducing fat fish for anti-obesity drug screening | 11.2 | 0 | 1 |
| Trauma Activation Patients: Evidence for Routine Alcohol and Illicit Drug Screening | 11.2 | 0 | 1 |
| A high-throughput fluorescence-based assay system for appetite-regulating gene and drug screening | 11.2 | 0 | 1 |
| Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity | 11.2 | 0 | 1 |
| Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells | 11.2 | 0 | 1 |
| Stage-regulated GFP Expression in Trypanosoma cruzi: applications from host-parasite interactions to drug screening | 11.2 | 0 | 1 |
| An over expression APP model for anti-Alzheimer disease drug screening created by zinc finger nuclease technology | 11.2 | 0 | 1 |
| Development and validation of a luminescence-based, medium-throughput assay for drug screening in Schistosoma mansoni | 11.2 | 0 | 1 |
| Characterization of a Novel Anti-Cancer Compound for Astrocytomas | 11.2 | 0 | 1 |
| Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia | 11.2 | 0 | 1 |
| Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites | 11.2 | 0 | 1 |
| Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening | 11.2 | 0 | 1 |
| High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam | 11.2 | 0 | 1 |
| Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening | 11.2 | 0 | 1 |
| Drug screening using model systems: some basics | 11.2 | 0 | 1 |
| Parkinson disease drug screening based on the interaction between D(2) dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresis | 11.2 | 0 | 1 |
| temporary employment agency activities | 11.2 | 0 | 1 |
| New colorimetric cytotoxicity assay for anticancer-drug screening | 11.2 | 0 | 1 |
| Multifocal epileptiform discharges | 11.2 | 0 | 1 |
| A new web-based operative skills assessment tool effectively tracks progression in surgical resident performance | 11.2 | 0 | 1 |
| National Center for Drug Screening | 11.2 | 0 | 1 |
| Workforce Solutions Northeast Texas | 11.2 | 0 | 1 |
| Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas | 11.2 | 0 | 1 |
| In vitro model of mycobacteria and HIV-1 co-infection for drug discovery | 11.2 | 0 | 1 |
| Functional expression of the 11 human Organic Anion Transporting Polypeptides in insect cells reveals that sodium fluorescein is a general OATP substrate | 11.2 | 0 | 1 |
| Enhancing reproducibility in cancer drug screening: how do we move forward? | 11.2 | 0 | 1 |
| Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia | 11.2 | 0 | 1 |
| Protein reporter bioassay systems for the phenotypic screening of candidate drugs: a mouse platform for anti-aging drug screening | 11.2 | 0 | 1 |
| Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms | 11.2 | 0 | 1 |
| Drug screening: A MuSIC-al way to identify drug pairs | 11.2 | 0 | 1 |
| Microfluidics-assisted in vitro drug screening and carrier production | 11.2 | 0 | 1 |
| High quality drug screening by capillary electrophoresis: A review | 11.2 | 0 | 1 |
| Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments | 11.2 | 0 | 1 |
| Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss | 11.2 | 0 | 1 |
| Chemical microarray: a new tool for drug screening and discovery | 11.2 | 0 | 1 |
| Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform | 11.2 | 0 | 1 |
| Interval estimation of quantile ratios applied to anti-cancer drug screening by xenograft experiments | 11.2 | 0 | 1 |
| Initial validation of a computerized version of the UCSD Performance-Based Skills Assessment (C-UPSA) for assessing functioning in schizophrenia | 11.2 | 0 | 1 |
| A microfluidic platform for high-sensitivity, real-time drug screening on C. elegans and parasitic nematodes | 11.2 | 0 | 1 |
| Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target | 11.2 | 0 | 1 |
| Novel Phenotypic Fluorescent Three-Dimensional Platforms for High-throughput Drug Screening and Personalized Chemotherapy | 11.2 | 0 | 1 |
| Observational skills assessment score: reliability in measuring amount and quality of use of the affected hand in unilateral cerebral palsy | 11.2 | 0 | 1 |
| Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow. | 11.2 | 0 | 1 |
| Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform | 11.2 | 0 | 1 |
| University of California, San Diego Performance-Based Skills Assessment | 11.2 | 0 | 1 |
| Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol. | 11.2 | 0 | 1 |
| Advantages and application of label-free detection assays in drug screening | 11.2 | 0 | 1 |
| Human iPSC-based cardiac microphysiological system for drug screening applications. | 11.2 | 0 | 1 |
| Statistical power analysis to estimate how many months of data are required to identify operating room staffing solutions to reduce labor costs and increase productivity | 11.2 | 0 | 1 |
| Early discovery drug screening using mass spectrometry | 11.2 | 0 | 1 |
| A New Bliss Independence Model to Analyze Drug Combination Data | 11.2 | 0 | 1 |
| Using National Medical Care Survey data to validate examination content on a performance-based clinical skills assessment for osteopathic physicians. | 11.2 | 0 | 1 |
| Category:Employment agencies of China | 11.2 | 0 | 1 |
| The radical treatment of hepatic hydatidosis with deep and multiple locations. The role of new technologies particularly in the case of multiple locations | 11.2 | 0 | 1 |
| Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation. | 11.2 | 0 | 1 |
| Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data | 11.2 | 0 | 1 |
| High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells. | 11.2 | 0 | 1 |
| Comprehensive drug screening by integrated use of gas chromatography/mass spectrometry and Remedi HS. | 11.2 | 0 | 1 |
| Development of the first metabolite-based LC-MS(n) urine drug screening procedure-exemplified for antidepressants. | 11.2 | 0 | 1 |
| Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening | 11.2 | 0 | 1 |
| Indications for Detection, Completion, and Retention Rates of Small Bowel Capsule Endoscopy Based on the 10-Year Data from the Korean Capsule Endoscopy Registry | 11.2 | 0 | 1 |
| Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry. | 11.2 | 0 | 1 |
| DNA repair protein levels vis-à-vis anticancer drug resistance in the human tumor cell lines of the National Cancer Institute drug screening program | 11.2 | 0 | 1 |
| Selective cytotoxicity evaluation in anticancer drug screening of fractionated plant extracts | 11.2 | 0 | 1 |
| Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition | 11.2 | 0 | 1 |
| Data mining a small molecule drug screening representative subset from NIH PubChem | 11.2 | 0 | 1 |
| Drug screening versus history in detection of substance use in ED psychiatric patients. | 11.2 | 0 | 1 |
| Integrating syndromic surveillance data across multiple locations: effects on outbreak detection performance. | 11.2 | 0 | 1 |
| A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases | 11.2 | 0 | 1 |
| Type I methionine aminopeptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening. | 11.2 | 0 | 1 |
| Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry (GC x GC-TOFMS) for drug screening and confirmation | 11.2 | 0 | 1 |
| Application of accurate mass measurement to urine drug screening | 11.2 | 0 | 1 |
| Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling | 11.2 | 0 | 1 |
| In vivo drug screening in human skin using femtosecond laser multiphoton tomography | 11.2 | 0 | 1 |
| Automated analysis of behavior: a computer-controlled system for drug screening and the investigation of learning | 11.2 | 0 | 1 |
| Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening | 11.2 | 0 | 1 |
| An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF. | 11.2 | 0 | 1 |
| Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening | 11.2 | 0 | 1 |
| Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening | 11.2 | 0 | 1 |
| Quantifying RNA-peptide interaction by single-quantum dot-based nanosensor: an approach for drug screening | 11.2 | 0 | 1 |
| Plasmodium falciparum: functional mitochondrial ADP/ATP transporter in Escherichia coli plasmic membrane as a tool for selective drug screening | 11.2 | 0 | 1 |
| High-content single-cell drug screening with phosphospecific flow cytometry | 11.2 | 0 | 1 |
| Value of patient time invested in the colonoscopy screening process: time requirements for colonoscopy study | 11.2 | 0 | 1 |
| poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening | 11.2 | 0 | 1 |
| Robust and systematic drug screening method using chemical arrays and the protein library: identification of novel inhibitors of carbonic anhydrase II. | 11.2 | 0 | 1 |
| A new method for in-silico drug screening and similarity search using molecular dynamics maximum volume overlap (MD-MVO) method | 11.2 | 0 | 1 |
| In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening | 11.2 | 0 | 1 |
| High-throughput in vivo genetic and drug screening using femtosecond laser nano-surgery, and microfluidics | 11.2 | 0 | 1 |
| Pooling in high-throughput drug screening. | 11.2 | 0 | 1 |
| Broad spectrum drug screening using liquid chromatography-hybrid triple quadrupole linear ion trap mass spectrometry | 11.2 | 0 | 1 |
| The development of a high-throughput measurement method of octanol/water distribution coefficient based on hollow fiber membrane solvent microextraction technique | 11.2 | 0 | 1 |
| Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis | 11.2 | 0 | 1 |
| Volume recruitment maneuvers are less deleterious than persistent low lung volumes in the atelectasis-prone rabbit lung during high-frequency oscillation. | 11.2 | 0 | 1 |
| The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure | 11.2 | 0 | 1 |
| Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group | 11.2 | 0 | 1 |
| Broad spectrum drug screening using electron-ionization gas chromatography-mass spectrometry (EI-GCMS). | 11.2 | 0 | 1 |
| A Hierarchical Model to Estimate Fish Abundance in Alpine Streams by using Removal Sampling Data from Multiple Locations | 11.2 | 0 | 1 |
| Alternative staffing services. Contract transcription. | 11.2 | 0 | 1 |
| Development of Chemical Compound Libraries for In Silico Drug Screening | 11.2 | 0 | 1 |
| Evaluation of a Low-Threshold/High-Tolerance Methadone Maintenance Treatment Clinic in Saint John, New Brunswick, Canada: One Year Retention Rate and Illicit Drug Use | 11.2 | 0 | 1 |
| Retention rate of physicians in public health administration agencies and their career paths in Japan | 11.2 | 0 | 1 |
| The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum | 11.2 | 0 | 1 |
| Drug screening to identify suppressors of GFAP expression | 11.2 | 0 | 1 |
| Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease | 11.2 | 0 | 1 |
| Patterns and Trends in Grade Retention Rates in the United States, 1995-2010. | 11.2 | 0 | 1 |
| Selection of in silico drug screening results by using universal active probes (UAPs). | 11.2 | 0 | 1 |
| Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer. | 11.2 | 0 | 1 |
| Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0. | 11.2 | 0 | 1 |
| In silico modeling predicts drug sensitivity of patient-derived cancer cells | 11.2 | 0 | 1 |
| Toward high-throughput drug screening on a chip-based parallel affinity separation platform. | 11.2 | 0 | 1 |
| Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening. | 11.2 | 0 | 1 |
| Drug screening for Huntington's disease and other neurodegenerative disorders | 11.2 | 0 | 1 |
| Measuring respiration of cultured cell with oxygen electrode as a metabolic indicator for drug screening | 11.2 | 0 | 1 |
| Prospects for drug screening using the reverse two-hybrid system | 11.2 | 0 | 1 |
| A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds | 11.2 | 0 | 1 |
| Assessment of re‐aggregated human pancreatic islets for secondary drug screening | 11.2 | 0 | 1 |
| Confidence from uncertainty--a multi-target drug screening method from robust control theory | 11.2 | 0 | 1 |
| Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder | 11.2 | 0 | 1 |
| Functional drug screening assay reveals potential glioma therapeutics | 11.2 | 0 | 1 |
| The application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp system | 11.2 | 0 | 1 |
| Usefulness of clinical algorithm as screening process to detected malaria in low-to-moderate transmission areas of scarce health related resources | 11.2 | 0 | 1 |
| Pneumothorax as a complication of lung volume recruitment | 11.2 | 0 | 1 |
| High-content drug screening with engineered musculoskeletal tissues | 11.2 | 0 | 1 |
| Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration | 11.2 | 0 | 1 |
| Drug screening in a zebrafish model of Duchenne muscular dystrophy. | 11.2 | 0 | 1 |
| Drug screening--beyond the bottleneck | 11.2 | 0 | 1 |
| Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment | 11.2 | 0 | 1 |
| Hydrogel-based 3D model of patient-derived prostate xenograft tumors suitable for drug screening | 11.2 | 0 | 1 |
| Limited utility of routine drug screening in trauma patients | 11.2 | 0 | 1 |
| UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults | 11.2 | 0 | 1 |
| Search for new drugs for treatment of tuberculosis | 11.2 | 0 | 1 |
| The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress | 11.2 | 0 | 1 |
| Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice | 11.2 | 0 | 1 |
| Postmortem Drug Screening by Non-Targeted and Targeted Ultra-Performance Liquid Chromatography-Mass Spectrometry Technology | 11.2 | 0 | 1 |
| Using the Zebrafish Photomotor Response for Psychotropic Drug Screening | 11.2 | 0 | 1 |
| Selecting at-risk first-grade readers for early intervention: Eliminating false positives and exploring the promise of a two-stage gated screening process | 11.2 | 0 | 1 |
| Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents | 11.2 | 0 | 1 |
| Basic training module for vitreoretinal surgery and the Casey Eye Institute Vitrectomy Indices Tool for Skills Assessment | 11.2 | 0 | 1 |
| Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening | 11.2 | 0 | 1 |
| Microfluidic System Based High Throughput Drug Screening System for Curcumin/TRAIL Combinational Chemotherapy in Human Prostate Cancer PC3 Cells | 11.2 | 0 | 1 |
| Genome rearrangement of influenza virus for anti-viral drug screening | 11.2 | 0 | 1 |
| Evaluation of a fluorescence-based method for antibabesial drug screening | 11.2 | 0 | 1 |
| The multilayered postconfluent cell culture as a model for drug screening | 11.2 | 0 | 1 |
| Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library | 11.2 | 0 | 1 |
| Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing | 11.2 | 0 | 1 |
| The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium | 11.2 | 0 | 1 |
| Visual spatial attention to multiple locations at once: the jury is still out. | 11.2 | 0 | 1 |
| A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity | 11.2 | 0 | 1 |
| Fluorescent TEM-1 β-lactamase with wild-type activity as a rapid drug sensor for in vitro drug screening | 11.2 | 0 | 1 |
| Mass Recruitment by Army Ants | 11.2 | 0 | 1 |
| A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. | 11.2 | 0 | 1 |
| Regulating DnaA complex assembly: it is time to fill the gaps. | 11.2 | 0 | 1 |
| Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control | 11.2 | 0 | 1 |
| Clinical skills assessment | 11.2 | 0 | 1 |
| Athletic trainers' attitudes toward drug screening of intercollegiate athletes. | 11.2 | 0 | 1 |
| Morphometric Variation in Pine Wood Nematodes, Bursaphelenchus xylophilus and B. mucronatus, Isolated from Multiple Locations in South Korea | 11.2 | 0 | 1 |
| A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening | 11.2 | 0 | 1 |
| The use ofXenopusoocytes in drug screening | 11.2 | 0 | 1 |
| LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays | 11.2 | 0 | 1 |
| NGS-Logistics: federated analysis of NGS sequence variants across multiple locations | 11.2 | 0 | 1 |
| Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening. | 11.2 | 0 | 1 |
| Assessment of a screening process to detect patients aged 60 years and over at high risk of hypothyroidism | 11.2 | 0 | 1 |
| An aptamer-based bio-barcode assay with isothermal recombinase polymerase amplification for cytochrome-c detection and anti-cancer drug screening | 11.2 | 0 | 1 |
| What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? | 11.2 | 0 | 1 |
| Urine drug screening in the medical setting | 11.2 | 0 | 1 |
| Technical and technological skills assessment in laparoscopic surgery | 11.2 | 0 | 1 |
| Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry | 11.2 | 0 | 1 |
| Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases | 11.2 | 0 | 1 |
| High Throughput, Polymeric Aqueous Two‐Phase Printing of Tumor Spheroids | 11.2 | 0 | 1 |
| A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses | 11.2 | 0 | 1 |
| Skills assessment of surgeons | 11.2 | 0 | 1 |
| Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library | 11.2 | 0 | 1 |
| Firearm Acquisition Without Background Checks: Results of a National Survey | 11.2 | 0 | 1 |
| Novel approaches to models of Alzheimer's disease pathology for drug screening and development | 11.2 | 0 | 1 |
| Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells | 11.2 | 0 | 1 |
| Surgical skills assessment: an ongoing debate | 11.2 | 0 | 1 |
| Tactical and operational response to major incidents: feasibility and reliability of skills assessment using novel virtual environments | 11.2 | 0 | 1 |
| Factors associated with "Ikigai" among members of a public temporary employment agency for seniors (Silver Human Resources Centre) in Japan; gender differences | 11.2 | 0 | 1 |
| Lung volume recruitment in multiple sclerosis | 11.2 | 0 | 1 |
| Drug screening and criminal prosecution of pregnant women | 11.2 | 0 | 1 |
| Large-scale recordings for drug screening in neural circuit systems | 11.2 | 0 | 1 |
| Toxicity from the use of niacin to beat urine drug screening | 11.2 | 0 | 1 |
| Sense and sensibility: the use of cell death biomarker assays in high-throughput anticancer drug screening and monitoring treatment responses | 11.2 | 0 | 1 |
| Urine drug screening in adolescents | 11.2 | 0 | 1 |
| Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis | 11.2 | 0 | 1 |
| Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity | 11.2 | 0 | 1 |
| Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening. | 11.2 | 0 | 1 |
| 50 years of preclinical anticancer drug screening: empirical to target-driven approaches. | 11.2 | 0 | 1 |
| Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay | 11.2 | 0 | 1 |
| In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor colony-forming assay | 11.2 | 0 | 1 |
| A Novel Leishmania major Amastigote Assay in 96-Well Format for Rapid Drug Screening and Its Use for Discovery and Evaluation of a New Class of Leishmanicidal Quinolinium Salts | 11.2 | 0 | 1 |
| Overview: the art of cancer drug screening: molecular target versus milieu-based screens. | 11.2 | 0 | 1 |
| Identification of compounds with potential antibacterial activity against Mycobacterium through structure-based drug screening | 11.2 | 0 | 1 |
| A potential model for drug screening by simulating the effect of shear stress in vivo on endothelium | 11.2 | 0 | 1 |
| Which clip? A prospective comparative study of retention rates of endoscopic clips on normal mucosa and ulcers in a porcine model | 11.2 | 0 | 1 |
| A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide. | 11.2 | 0 | 1 |
| Clinical Validation of a Highly Sensitive GC-MS Platform for Routine Urine Drug Screening and Real-Time Reporting of up to 212 Drugs | 11.2 | 0 | 1 |
| Communication skills assessment: the perceptions of medical students at the University of Nottingham | 11.2 | 0 | 1 |
| The Natural Compound Cantharidin Induces Cancer Cell Death through Inhibition of Heat Shock Protein 70 (HSP70) and Bcl-2-associated Athanogene Domain 3 (BAG3) Expression by Blocking Heat Shock Factor 1 (HSF1) Binding to Promoters | 11.2 | 0 | 1 |
| From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials | 11.2 | 0 | 1 |
| Volumetric analysis and indocyanine green retention rate at 15 min as predictors of post‐hepatectomy liver failure | 11.2 | 0 | 1 |
| Objective Structured Clinical Examinations Provide Valid Clinical Skills Assessment in Emergency Medicine Education | 11.2 | 0 | 1 |
| Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. | 11.2 | 0 | 1 |
| Multiple Locations of Peptides in the Hydrocarbon Core of Gel-Phase Membranes Revealed by Peptide 13C to Lipid 2H Rotational-Echo Double-Resonance Solid-State Nuclear Magnetic Resonance | 11.2 | 0 | 1 |
| FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease | 11.2 | 0 | 1 |
| DSE‐FRET: A new anticancer drug screening assay for DNA binding proteins | 11.2 | 0 | 1 |
| Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion. | 11.2 | 0 | 1 |
| Drug susceptibility of matrix‐encapsulated Candida albicans nano‐biofilms | 11.2 | 0 | 1 |
| Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety | 11.2 | 0 | 1 |
| Identification of Novel Potential Antibiotics against Staphylococcus Using Structure-Based Drug Screening Targeting Dihydrofolate Reductase | 11.2 | 0 | 1 |
| Universal Alcohol/Drug Screening in Prenatal Care: A Strategy for Reducing Racial Disparities? Questioning the Assumptions | 11.2 | 0 | 1 |
| Electronic Medical Records and Improving the Quality of the Screening Process | 11.2 | 0 | 1 |
| Visualization of Positive Transcription Elongation Factor b (P-TEFb) Activation in Living Cells | 11.2 | 0 | 1 |
| McGill Ingestive Skills Assessment (MISA): development and first field test of an evaluation of functional ingestive skills of elderly persons | 11.2 | 0 | 1 |
| UCSD SORT Test (U-SORT): Examination of a newly developed organizational skills assessment tool for severely mentally ill adults | 11.2 | 0 | 1 |
| Bioluminescence and chemiluminescence in drug screening | 11.2 | 0 | 1 |
| A method to enhance the hit ratio by a combination of structure-based drug screening and ligand-based screening. | 11.2 | 0 | 1 |
| Multiplexed phosphospecific flow cytometry enables large‐scale signaling profiling and drug screening in blood platelets | 11.2 | 0 | 1 |
| A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma | 11.2 | 0 | 1 |
| Exploring Weak Ligand–Protein Interactions by Long‐Lived NMR States: Improved Contrast in Fragment‐Based Drug Screening | 11.2 | 0 | 1 |
| 3'-Azido-3'-deoxythymidine prevents induction of murine acquired immunodeficiency syndrome in C57BL/10 mice infected with LP-BM5 murine leukemia viruses, a possible animal model for antiretroviral drug screening | 11.2 | 0 | 1 |
| Expression of an Mg 2+ -Dependent HIV-1 RNase H Construct for Drug Screening | 11.2 | 0 | 1 |
| Automated fast perfusion of Xenopus oocytes for drug screening | 11.2 | 0 | 1 |
| Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose | 11.2 | 0 | 1 |
| Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia | 11.2 | 0 | 1 |
| AN APPRAISAL OF ANIMAL DRUG SCREENING TECHNIQUES USED IN PSYCHOPHARMACOLOGY. | 11.2 | 0 | 1 |
| Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer | 11.2 | 0 | 1 |
| Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening. | 11.2 | 0 | 1 |
| Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. | 11.2 | 0 | 1 |
| Cellular impedance biosensors for drug screening and toxin detection. | 11.2 | 0 | 1 |
| Identification of Novel Radiosensitizers in a High-Throughput, Cell-Based Screen for DSB Repair Inhibitors | 11.2 | 0 | 1 |
| Anticancer drug screening and discovery in the 1990s: a European perspective | 11.2 | 0 | 1 |
| LOCAL KERNEL CANONICAL CORRELATION ANALYSIS WITH APPLICATION TO VIRTUAL DRUG SCREENING. | 11.2 | 0 | 1 |
| Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion | 11.2 | 0 | 1 |
| Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells | 11.2 | 0 | 1 |
| Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of doxorubicin. | 11.2 | 0 | 1 |
| Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma | 11.2 | 0 | 1 |
| Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening | 11.2 | 0 | 1 |
| Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production | 11.2 | 0 | 1 |
| An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening. | 11.2 | 0 | 1 |
| Re: Discovery and Characterization of Small Molecules that Target the GTPase Ral | 11.2 | 0 | 1 |
| Drug screening strategy for human membrane proteins: from NMR protein backbone structure to in silica- and NMR-screened hits | 11.2 | 0 | 1 |
| Flexible and waterproof micro-sensors to uncover zebrafish circadian rhythms: The next generation of cardiac monitoring for drug screening | 11.2 | 0 | 1 |
| Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening. | 11.2 | 0 | 1 |
| JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression | 11.2 | 0 | 1 |
| Co-treatment of Salinomycin Sensitizes AZD5363-treated Cancer Cells Through Increased Apoptosis | 11.2 | 0 | 1 |
| Criminal background checks: necessary admission criteria? | 11.2 | 0 | 1 |
| Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs | 11.2 | 0 | 1 |
| Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome(1,2,3). | 11.2 | 0 | 1 |
| Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. | 11.2 | 0 | 1 |
| A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening | 11.2 | 0 | 1 |
| High-throughput imaging: Focusing in on drug discovery in 3D | 11.2 | 0 | 1 |
| Tools for automating the imaging of zebrafish larvae | 11.2 | 0 | 1 |
| Drug screening boosted by hyperpolarized long-lived states in NMR | 11.2 | 0 | 1 |
| Clinical Skills Assessment: The Effects of Moving Certification Requirements Into Neurology, Child Neurology, and Psychiatry Residency Training | 11.2 | 0 | 1 |
| Broad-Spectrum Drug Screening Using Liquid Chromatography-Hybrid Triple-Quadrupole Linear Ion Trap Mass Spectrometry | 11.2 | 0 | 1 |
| High-Resolution Mass Spectrometry for Untargeted Drug Screening | 11.2 | 0 | 1 |
| A biomimetic Schlemm's canal inner wall: A model to study outflow physiology, glaucoma pathology and high-throughput drug screening. | 11.2 | 0 | 1 |
| Controlling the screening process of a nanoscaled space charge region by minority carriers | 11.2 | 0 | 1 |
| Can Perceptuo-Motor Skills Assessment Outcomes in Young Table Tennis Players (7-11 years) Predict Future Competition Participation and Performance? An Observational Prospective Study | 11.2 | 0 | 1 |
| From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity | 11.2 | 0 | 1 |
| High throughput drug screening | 11.2 | 0 | 1 |
| Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients | 11.2 | 0 | 1 |
| Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry | 11.2 | 0 | 1 |
| Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures. | 11.2 | 0 | 1 |
| Computational protein-ligand docking and virtual drug screening with the AutoDock suite | 11.2 | 0 | 1 |
| Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma | 11.2 | 0 | 1 |
| Intramers and aptamers: applications in protein-function analyses and potential for drug screening | 11.2 | 0 | 1 |
| Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening | 11.2 | 0 | 1 |
| A High-Throughput Drug Screening Strategy for Detecting Rhodopsin P23H Mutant Rescue and Degradation | 11.2 | 0 | 1 |
| Proteome-wide drug screening using mass spectrometric imaging of bead-arrays | 11.2 | 0 | 1 |
| A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegans | 11.2 | 0 | 1 |
| Development of a vestibular schwannoma xenograft zebrafish model for in vivo antitumor drug screening. | 11.2 | 0 | 1 |
| GINA and preemployment criminal background checks | 11.2 | 0 | 1 |
| The programmed cell death GLuc PCA library - a powerful tool for pathway discovery and drug screening | 11.2 | 0 | 1 |
| Soil-Transmitted Helminth Eggs Are Present in Soil at Multiple Locations within Households in Rural Kenya | 11.2 | 0 | 1 |
| Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening | 11.2 | 0 | 1 |
| Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening. | 11.2 | 0 | 1 |
| Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer | 11.2 | 0 | 1 |
| The Human Model: Changing Focus on Autism Research | 11.2 | 0 | 1 |
| Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine | 11.2 | 0 | 1 |
| Web-Based Virtual Microscopy of Digitized Blood Slides for Malaria Diagnosis: An Effective Tool for Skills Assessment in Different Countries and Environments | 11.2 | 0 | 1 |
| Clinical skills assessment of procedural and advanced communication skills: performance expectations of residency program directors | 11.2 | 0 | 1 |
| A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells | 11.2 | 0 | 1 |
| Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions | 11.2 | 0 | 1 |
| The early feeding skills assessment for preterm infants | 11.2 | 0 | 1 |
| Identifying elements of job satisfaction to improve retention rates in healthcare. | 11.2 | 0 | 1 |
| Scoring standardized patient examinations: lessons learned from the development and administration of the ECFMG Clinical Skills Assessment (CSA). | 11.2 | 0 | 1 |
| Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening | 11.2 | 0 | 1 |
| High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma | 11.2 | 0 | 1 |
| Covalent Immobilization of Human Placental 17β-Hydroxysteroid Dehydrogenase Type 1 onto Glutaraldehyde Activated Silica Coupled with LC-TOF/MS for Anti-Cancer Drug Screening Applications. | 11.2 | 0 | 1 |
| Development of an in vitro drug screening assay using Schistosoma haematobium schistosomula | 11.2 | 0 | 1 |
| Droplet Microfluidic System with On-Demand Trapping and Releasing of Droplet for Drug Screening Applications. | 11.2 | 0 | 1 |
| A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. | 11.2 | 0 | 1 |
| Estimation of second polar body retention rate after conventional insemination and intracytoplasmic sperm injection: in vitro observations from more than 5000 human oocytes | 11.2 | 0 | 1 |
| Cell lines as in vitro models for drug screening and toxicity studies | 11.2 | 0 | 1 |
| Participant retention practices in longitudinal clinical research studies with high retention rates | 11.2 | 0 | 1 |
| Candida albicans biofilm chip (CaBChip) for high-throughput antifungal drug screening | 11.2 | 0 | 1 |
| Epinephrine at doses used in dentistry deteriorates platelet retention rate | 11.2 | 0 | 1 |
| Training frontline workforce on psychosis management: a prospective study of training effects | 11.2 | 0 | 1 |
| Identification of Social Anxiety in Schools: the Utility of a Two-Step Screening Process | 11.2 | 0 | 1 |
| Nurses' promise to safeguard the public: is it time for nationally mandated background checks? | 11.2 | 0 | 1 |
| Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening | 11.2 | 0 | 1 |
| Spontaneously-forming spheroids as anin vitrocancer cell model for anticancer drug screening | 11.2 | 0 | 1 |
| In silico structure-based drug screening of novel antimycobacterial pharmacophores by DOCK-GOLD tandem screening | 11.2 | 0 | 1 |
| Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2. | 11.2 | 0 | 1 |
| Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies | 11.2 | 0 | 1 |
| Influence of a three-dimensional, microarray environment on human Cell culture in drug screening systems | 11.2 | 0 | 1 |
| Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease | 11.2 | 0 | 1 |
| G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways | 11.2 | 0 | 1 |
| Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment | 11.2 | 0 | 1 |
| Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome. | 11.2 | 0 | 1 |
| Tuberculosis in pregnancy - case studies and a review of Australia's screening process. | 11.2 | 0 | 1 |
| Baculoviruses and mammalian cell-based assays for drug screening | 11.2 | 0 | 1 |
| Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases | 11.2 | 0 | 1 |
| The Dunedin program, a Florida geriatric screening process: design and initial data | 11.2 | 0 | 1 |
| A comparison of clinical efficacy between high frequency oscillatory ventilation and conventional ventilation with lung volume recruitment in pediatric acute respiratory distress syndrome: A randomized controlled trial | 11.2 | 0 | 1 |
| Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. | 11.2 | 0 | 1 |
| Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system | 11.2 | 0 | 1 |
| Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer | 11.2 | 0 | 1 |
| Potential application of embryonic stem cells in Parkinson's disease: drug screening and cell therapy | 11.2 | 0 | 1 |
| Automated imaging and quantitation of tumor cells and CFU-GM colonies in microcapillary cultures: toward therapeutic index-based drug screening | 11.2 | 0 | 1 |
| Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection | 11.2 | 0 | 1 |
| Focus on three domains for the clinical skills assessment exam. | 11.2 | 0 | 1 |
| Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate. | 11.2 | 0 | 1 |
| Evaluation of California's Alcohol and Drug Screening and Brief Intervention Project for Emergency Department Patients | 11.2 | 0 | 1 |
| Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing | 11.2 | 0 | 1 |
| The substances and choices scale (SACS)--the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people. | 11.2 | 0 | 1 |
| Transparent communication strategy on GMOs: will it change public opinion? | 11.2 | 0 | 1 |
| A novel non-radioactive assay for HIV-RT (RdDp) based on pyrosequencing for high-throughput drug screening | 11.2 | 0 | 1 |
| First through Eighth Grade Retention Rates for All 50 States: A New Method and Initial Results | 11.2 | 0 | 1 |
| A case study of SMART attributes: a qualitative assessment of generalizability, retention rate, and trial quality | 11.2 | 0 | 1 |
| Development of selective blockers for Ca²(+)-activated Cl channel using Xenopus laevis oocytes with an improved drug screening strategy | 11.2 | 0 | 1 |
| Brain Aggregates: An EffectiveIn VitroCell Culture System Modeling Neurodegenerative Diseases | 11.2 | 0 | 1 |
| Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei. | 11.2 | 0 | 1 |
| Cardiovascular complications among individuals with amphetamine-positive urine drug screening admitted to a tertiary care hospital in Riyadh | 11.2 | 0 | 1 |
| Urine drug screening: practical guide for clinicians | 11.2 | 0 | 1 |
| Corneal epithelial cell cultures as a tool for research, drug screening and testing | 11.2 | 0 | 1 |
| Organizational factors and the cancer screening process | 11.2 | 0 | 1 |
| An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein | 11.2 | 0 | 1 |
| Approved: Elimination of periodic performance review for health care staffing services certification. | 11.2 | 0 | 1 |
| Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods. | 11.2 | 0 | 1 |
| Indication of nerve growth factor binding components from herbal extracts by HerboChip: a platform for drug screening on a chip. | 11.2 | 0 | 1 |
| Metabolite profiling studies in Saccharomyces cerevisiae: an assisting tool to prioritize host targets for antiviral drug screening | 11.2 | 0 | 1 |
| Non-thermal modulation of sudomotor function during static exercise and the impact of intensity and muscle-mass recruitment | 11.2 | 0 | 1 |
| Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus | 11.2 | 0 | 1 |
| MedusaScore: an accurate force field-based scoring function for virtual drug screening | 11.2 | 0 | 1 |
| Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment. | 11.2 | 0 | 1 |
| Computer-based endoscopy simulation: emerging roles in teaching and professional skills assessment | 11.2 | 0 | 1 |
| Single-bead, single-molecule, single-cell fluorescence: technologies for drug screening and target validation | 11.2 | 0 | 1 |
| An assessment of anxiolytic drug screening tests: hormetic dose responses predominate | 11.2 | 0 | 1 |
| Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules | 11.2 | 0 | 1 |
| Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia | 11.2 | 0 | 1 |
| Development of a research ethics knowledge and analytical skills assessment tool | 11.2 | 0 | 1 |
| An overview of drug screening using primary and embryonic stem cells. | 11.2 | 0 | 1 |
| A Recently Discovered Pathogenic Paramyxovirus, Sosuga Virus, is Present in Rousettus aegyptiacus Fruit Bats at Multiple Locations in Uganda | 11.2 | 0 | 1 |
| Versatile casein kinase 1: multiple locations and functions. | 11.2 | 0 | 1 |
| The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. | 11.2 | 0 | 1 |
| Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes | 11.2 | 0 | 1 |
| Integration of ligand-based drug screening with structure-based drug screening by combining maximum volume overlapping score with ligand docking | 11.2 | 0 | 1 |
| An evaluation of the effectiveness of the Zambian Health Worker Retention Scheme (ZHWRS) for rural areas | 11.2 | 0 | 1 |
| Development of a Social Skills Assessment Screening Scale for Psychiatric Rehabilitation Settings: A Pilot Study. | 11.2 | 0 | 1 |
| Arbitrarily Accessible 3D Microfluidic Device for Combinatorial High-Throughput Drug Screening | 11.2 | 0 | 1 |
| Arthroscopic skills assessment and use of box model for training in arthroscopic surgery using Sawbones - "FAST" workstation | 11.2 | 0 | 1 |
| Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection | 11.2 | 0 | 1 |
| The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment | 11.2 | 0 | 1 |
| Improved behavioral response as a valid biomarker for drug screening program in transgenic rodent models of tauopathies | 11.2 | 0 | 1 |
| Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration | 11.2 | 0 | 1 |
| Microfabricated electrospun collagen membranes for 3-D cancer models and drug screening applications. | 11.2 | 0 | 1 |
| Correlative effect between in vivo hollow fiber assay and xenografts assay in drug screening | 11.2 | 0 | 1 |
| Computational Systems Bioinformatics and Bioimaging for Pathway Analysis and Drug Screening | 11.2 | 0 | 1 |
| A Microchip for High-throughput Axon Growth Drug Screening. | 11.2 | 0 | 1 |
| Structure-based drug screening and ligand-based drug screening with machine learning. | 11.2 | 0 | 1 |
| Development of a Brazilian Portuguese adapted version of the Gap-Kalamazoo communication skills assessment form. | 11.2 | 0 | 1 |
| Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease. | 11.2 | 0 | 1 |
| Candidate quality of care indicators for localized bladder cancer | 11.2 | 0 | 1 |
| Conjugated polyelectrolytes as new platforms for drug screening | 11.2 | 0 | 1 |
| Remediation techniques for student performance problems after a comprehensive clinical skills assessment | 11.2 | 0 | 1 |
| Genome Sequences of Diverse Human Cytomegalovirus Strains with Utility in Drug Screening and Vaccine Evaluation. | 11.2 | 0 | 1 |
| Comparative drug screening in NUT midline carcinoma | 11.2 | 0 | 1 |
| Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review | 11.2 | 0 | 1 |
| Lung volume recruitment acutely increases respiratory system compliance in individuals with severe respiratory muscle weakness. | 11.2 | 0 | 1 |
| In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma | 11.2 | 0 | 1 |
| Post Processing of Protein-Compound Docking for Fragment-Based Drug Discovery (FBDD): In-Silico Structure-Based Drug Screening and Ligand-Binding Pose Prediction | 11.2 | 0 | 1 |
| Structural ensemble in computational drug screening | 11.2 | 0 | 1 |
| The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design | 11.2 | 0 | 1 |
| Calcium channelopathies in inherited neurological disorders: relevance to drug screening for acquired channel disorders. | 11.2 | 0 | 1 |
| Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. | 11.2 | 0 | 1 |
| Emerging roles for β-arrestin-1 in the control of the pancreatic β-cell function and mass: new therapeutic strategies and consequences for drug screening | 11.2 | 0 | 1 |
| Application of the pharmacological screening process | 11.2 | 0 | 1 |
| Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease | 11.2 | 0 | 1 |
| Cellular models for disease exploring and drug screening | 11.2 | 0 | 1 |
| Lessons from (patho)physiological tissue stiffness and their implications for drug screening, drug delivery and regenerative medicine | 11.2 | 0 | 1 |
| Attention to gender in communication skills assessment instruments in medical education: a review | 11.2 | 0 | 1 |
| Stem Cells for Drug Screening | 11.2 | 0 | 1 |
| A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy | 11.2 | 0 | 1 |
| Promoting Adult Hippocampal Neurogenesis: A Novel Strategy for Antidepressant Drug Screening | 11.2 | 0 | 1 |
| Human pluripotent stem cells for genetic disease modeling and drug screening. | 11.2 | 0 | 1 |
| Chemical genetics and drug screening in Drosophila cancer models | 11.2 | 0 | 1 |
| Human pluripotent stem cells for disease modelling and drug screening | 11.2 | 0 | 1 |
| Exercise and motor training in people with Parkinson's disease: a systematic review of participant characteristics, intervention delivery, retention rates, adherence, and adverse events in clinical trials | 11.2 | 0 | 1 |
| Cardiomyocytes derived from human pluripotent stem cells for drug screening | 11.2 | 0 | 1 |
| Novel Educational Approach for Medical Students: Improved Retention Rates Using Interactive Medical Software Compared with Traditional Lecture-Based Format | 11.2 | 0 | 1 |
| Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening. | 11.2 | 0 | 1 |
| Structure-based drug screening for G-protein-coupled receptors | 11.2 | 0 | 1 |
| Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases | 11.2 | 0 | 1 |
| Novel educational approach for medical students: improved retention rates using interactive medical software compared with traditional lecture-based format | 11.2 | 0 | 1 |
| Perinatal illicit drug screening practices in mother-newborn dyads at a university hospital serving rural/semi-urban communities: translation of research to quality improvement. | 11.2 | 0 | 1 |
| Advances in flow cytometry for drug screening. | 11.2 | 0 | 1 |
| Current status of drug screening and disease modelling in human pluripotent stem cells. | 11.2 | 0 | 1 |
| The use of mammalian two-hybrid technologies for high-throughput drug screening | 11.2 | 0 | 1 |
| Temporomandibular disorders: a practical screening process | 11.2 | 0 | 1 |
| Pluripotency and Targeted Reprogramming: Strategies, Disease Modeling and Drug Screening | 11.2 | 0 | 1 |
| Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells | 11.2 | 0 | 1 |
| Novel approaches to glioma drug design and drug screening. | 11.2 | 0 | 1 |
| Multiple Locations of Advance Care Planning Documentation in an Electronic Health Record: Are They Easy to Find? | 11.2 | 0 | 1 |
| A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening | 11.2 | 0 | 1 |
| Role of Urine Drug Screening in the Medical Clearance of Pediatric Psychiatric Patients | 11.2 | 0 | 1 |
| Recruitment and retention rates in behavioral trials involving patients and a support person: a systematic review. | 11.2 | 0 | 1 |
| Quantum dot approaches for target-based drug screening and multiplexed active biosensing | 11.2 | 0 | 1 |
| Modeling colorectal cancer as a 3-dimensional disease in a dish: the case for drug screening using organoids, zebrafish, and fruit flies. | 11.2 | 0 | 1 |
| 3Din vitrotissue models and their potential for drug screening | 11.2 | 0 | 1 |
| An Electronic Safety Screening Process during Inpatient Computerized Physician Order Entry Improves the Efficiency of Magnetic Resonance Imaging Exams | 11.2 | 0 | 1 |
| Engineering three-dimensional cardiac microtissues for potential drug screening applications | 11.2 | 0 | 1 |
| Technical skills assessment toolbox: a review using the unitary framework of validity. | 11.2 | 0 | 1 |
| Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK | 11.2 | 0 | 1 |
| Evaluation of methods of detecting cell reactive oxygen species production for drug screening and cell cycle studies | 11.2 | 0 | 1 |
| Eye tracking for skills assessment and training: a systematic review | 11.2 | 0 | 1 |
| A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center | 11.2 | 0 | 1 |
| Bioengineering 3D environments for cancer models | 11.2 | 0 | 1 |
| Small RNAs: the qualified candidates for gene manipulation in diverse clinical pathologies. | 11.2 | 0 | 1 |
| Pluripotent Stem Cells as a Platform for Cardiac Arrhythmia Drug Screening | 11.2 | 0 | 1 |
| Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy | 11.2 | 0 | 1 |
| Metabolomics in cell culture—A strategy to study crucial metabolic pathways in cancer development and the response to treatment | 11.2 | 0 | 1 |
| Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification | 11.2 | 0 | 1 |
| Communication skills assessment in the final postgraduate years to established practice: a systematic review | 11.2 | 0 | 1 |
| The Role of Matrix Compliance on Cell Responses to Drugs and Toxins: Towards Predictive Drug Screening Platforms | 11.2 | 0 | 1 |
| The Discovery Channel: microfluidics and microengineered systems in drug screening | 11.2 | 0 | 1 |
| Reprint of: Highthroughtput analysis of behavior for drug discovery | 11.2 | 0 | 1 |
| Using ontology-based semantic similarity to facilitate the article screening process for systematic reviews. | 11.2 | 0 | 1 |
| The power of the yeast two-hybrid system in the identification of novel drug targets: building and modulating PPP1 interactomes | 11.2 | 0 | 1 |
| Perioperative Management in the Patient with Substance Abuse | 11.2 | 0 | 1 |
| The Korean Version of the University of California San Diego Performance-based Skills Assessment: Reliability and Validity | 11.2 | 0 | 1 |
| Nontechnical Skills Assessment After Simulation-Based Continuing Medical Education | 11.2 | 0 | 1 |
| Time-efficient laparoscopic skills assessment using an augmented-reality simulator | 11.2 | 0 | 1 |
| Long-term retention rate of zonisamide in patients with epilepsy: an observational study | 11.2 | 0 | 1 |
| Pathophysiologically relevant in vitro tumor models for drug screening | 11.2 | 0 | 1 |
| What Can a Urine Drug Screening Immunoassay Really Tell Us? | 11.2 | 0 | 1 |
| Season of birth is related to child retention rates, achievement, and rate of diagnosis of specific LD. | 11.2 | 0 | 1 |
| By the numbers. Largest healthcare staffing firms ranked by 2003 healthcare staffing revenue. | 11.2 | 0 | 1 |
| Drug Screening to Treat Early-Onset Eye Diseases: Can Zebrafish Expedite the Discovery? | 11.2 | 0 | 1 |
| Acute Urinary Retention Rates in the General Male Population and in Adult Men With Lower Urinary Tract Symptoms Participating in Pharmacotherapy Trials: A Literature Review | 11.2 | 0 | 1 |
| Group and mass recruitment in ant colonies: the influence of contact rates | 11.2 | 0 | 1 |
| Advancements in in vitro hepatic models: application for drug screening and therapeutics | 11.2 | 0 | 1 |
| Three dimensionalde novomicro bone marrow and its versatile application in drug screening and regenerative medicine | 11.2 | 0 | 1 |
| Pluripotent stem cells as a cellular model for skin: relevance for physiopathology, cell/gene therapy and drug screening | 11.2 | 0 | 1 |
| Theoretical analysis of the communication system for chemical mass recruitment in ants | 11.2 | 0 | 1 |
| Using MEDLINE Elemental Similarity to Assist in the Article Screening Process for Systematic Reviews | 11.2 | 0 | 1 |
| Evidence for a fixed capacity limit in attending multiple locations. | 11.2 | 0 | 1 |
| Mesenchymal‐Mode Migration Assay and Antimetastatic Drug Screening with High‐Throughput Microfluidic Channel Networks | 11.2 | 0 | 1 |
| iPSC-based drug screening for Huntington׳s disease | 11.2 | 0 | 1 |
| Approach to Modeling, Therapy Evaluation, Drug Selection, and Biomarker Assessments for a Multicenter Pre-Clinical Drug Screening Consortium for Acute Therapies in Severe Traumatic Brain Injury: Operation Brain Trauma Therapy | 11.2 | 0 | 1 |
| Clinical utility of the UCSD Performance-Based Skills Assessment-Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties. | 11.2 | 0 | 1 |
| Can We Increase the Value and Decrease the Cost of Clinical Skills Assessment? | 11.2 | 0 | 1 |
| The Computerized Perceptual Motor Skills Assessment: A new visual perceptual motor skills evaluation tool for children in early elementary grades. | 11.2 | 0 | 1 |
| Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry | 11.2 | 0 | 1 |
| Seizure Detection Software Used to Complement the Visual Screening Process for Long-Term EEG Monitoring | 11.2 | 0 | 1 |
| Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug Screening | 11.2 | 0 | 1 |
| A teaching skills assessment tool inspired by the Calgary-Cambridge model and the patient-centered approach | 11.2 | 0 | 1 |
| High-content drug screening for rare diseases | 11.2 | 0 | 1 |
| Quality Metrics and Systems Transformation: Are We Advancing Alcohol and Drug Screening in Primary Care? | 11.2 | 0 | 1 |
| Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis. | 11.2 | 0 | 1 |
| Challenges for Detecting Valproic Acid in a Nontargeted Urine Drug Screening Method. | 11.2 | 0 | 1 |
| Radioligand binding to intact cells as a tool for extended drug screening in a representative physiological context | 11.2 | 0 | 1 |
| The knowledge and skills assessment (KASA) tool in the Australian Dementia Behaviour Management Advisory Service: development and initial testing | 11.2 | 0 | 1 |
| The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine | 11.2 | 0 | 1 |
| Validity evidence of non-technical skills assessment instruments in simulated anaesthesia crisis management | 11.2 | 0 | 1 |
| Gaze-based Technology as a Tool for Surgical Skills Assessment and Training in Urology. | 11.2 | 0 | 1 |
| Personalization of the medical treatment of solid tumours using patient-derived tumour explants (Review) | 11.2 | 0 | 1 |
| Background Checks for all Gun Buyers and Gun Violence Restraining Orders: State Efforts to Keep Guns from High-Risk Persons | 11.2 | 0 | 1 |
| Bioanalytical approaches for the detection of protein acetylation-related enzymes | 11.2 | 0 | 1 |
| Medical Examination of Aliens--Revisions to Medical Screening Process. Final rule | 11.2 | 0 | 1 |
| Microprinted tumor spheroids enable anti-cancer drug screening | 11.2 | 0 | 1 |
| Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief | 11.2 | 0 | 1 |
| Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities | 11.2 | 0 | 1 |
| Three-dimensional cell culture models for anticancer drug screening: Worth the effort? | 11.2 | 0 | 1 |
| Retention Rates in New Contact Lens Wearers | 11.2 | 0 | 1 |
| Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read-outs | 11.2 | 0 | 1 |
| Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target | 11.2 | 0 | 1 |
| Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer | 11.2 | 0 | 1 |
| Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis | 11.2 | 0 | 1 |
| Development of a Self-Rated Mixed Methods Skills Assessment: The National Institutes of Health Mixed Methods Research Training Program for the Health Sciences. | 11.2 | 0 | 1 |
| Modeling Niemann Pick type C1 using human embryonic and induced pluripotent stem cells | 11.2 | 0 | 1 |
| Fingerprint-based background checks for personal care workers: Stakeholder views of policy criteria | 11.2 | 0 | 1 |
| Evaluating facility-based antiretroviral therapy programme effectiveness: a pilot study comparing viral load suppression and retention rates | 11.2 | 0 | 1 |
| Thermo-responsive polymer aided spheroid culture in cryogel based platform for high throughput drug screening | 11.2 | 0 | 1 |
| High Throughput Screening for Colorectal Cancer Specific Compounds | 11.2 | 0 | 1 |
| A Multi-Modality CMOS Sensor Array for Cell-Based Assay and Drug Screening. | 11.2 | 0 | 1 |
| C-SPADE: a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms | 11.2 | 0 | 1 |
| Microfluidic cell chips for high-throughput drug screening. | 11.2 | 0 | 1 |
| Determinants of rural Australian primary health care worker retention: A synthesis of key evidence and implications for policymaking | 11.2 | 0 | 1 |
| IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies. | 11.2 | 0 | 1 |
| Patterning hypoxic multicellular spheroids in a 3D matrix – a promising method for anti‐tumor drug screening | 11.2 | 0 | 1 |
| Microtechnology-based organ systems and whole-body models for drug screening | 11.2 | 0 | 1 |
| Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells | 11.2 | 0 | 1 |
| Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening. | 11.2 | 0 | 1 |
| 3D Printing of Tissue Engineered Constructs for In Vitro Modeling of Disease Progression and Drug Screening | 11.2 | 0 | 1 |
| Recent Developments of Three-Dimensional Paper-Based Electrochemical Devices for Cancer Cell Detection and Anticancer Drug Screening. | 11.2 | 0 | 1 |
| Legal and regulatory framework for health worker retention in Mozambique: Public health law research to strengthen health systems and services | 11.2 | 0 | 1 |
| A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening. | 11.2 | 0 | 1 |
| Bi-content micro-collagen chip provides contractility-based biomechanical readout for phenotypic drug screening with expanded and profiled targets | 11.2 | 0 | 1 |
| Can an early perceptuo-motor skills assessment predict future performance in youth table tennis players? An observational study (1998-2013). | 11.2 | 0 | 1 |
| Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling | 11.2 | 0 | 1 |
| Impact of the spheroid model complexity on drug response | 11.2 | 0 | 1 |
| Antineoplastic effects of deoxypodophyllotoxin, a potent cytotoxic agent of plant origin, on glioblastoma U-87 MG and SF126 cells | 11.2 | 0 | 1 |
| Clip retention rates and rates of residual polyp at the base of retained clips on colorectal EMR sites | 11.2 | 0 | 1 |
| Finding new drugs to enhance anion secretion in cystic fibrosis: Toward suitable systems for better drug screening. Report on the pre-conference meeting to the 12th ECFS Basic Science Conference, Albufeira, 25-28 March 2015. | 11.2 | 0 | 1 |
| Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers | 11.2 | 0 | 1 |
| Multisystemic Disease Modeling of Liver-Derived Protein Folding Disorders Using Induced Pluripotent Stem Cells (iPSCs) | 11.2 | 0 | 1 |
| Establishment of a rapid drug screening system based on embryonic stem cells | 11.2 | 0 | 1 |
| Pluripotent stem cells for disease modeling and drug screening: new perspectives for treatment of cystic fibrosis? | 11.2 | 0 | 1 |
| Comparative evaluation of in vitro cytotoxic effects among parent abietyl alcohol and novel fatty acid ester derivatives against MCF7 and hepatocellular carcinoma cell lines | 11.2 | 0 | 1 |
| Utilization of an automated pipetting system in the cell line-based screening of the activity of a DNA-damaging anti-tumour drug | 11.2 | 0 | 1 |
| Hybrids of Phenylsulfonylfuroxan and Coumarin as Potent Antitumor Agents | 11.2 | 0 | 1 |
| Synthesis, characterization, cytotoxicity of mixed ligand complexes of palladium(II) with dipyrido[3,2-d:2′,3′-f]quinoxaline/dipyrido[3,2-a:2′,3′-c](6,7,8,9-tetrahydro)phenazine and 4-toluensulfonyl-L-amino acid dianion | 11.2 | 0 | 1 |
| Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder | 11.2 | 0 | 1 |
| Tapered Microtract Array Platform for Antimigratory Drug Screening of Human Glioblastoma Multiforme | 11.2 | 0 | 1 |
| Drug Screening in Neonates | 11.2 | 0 | 1 |
| Rapid In-vitro Testing for Chemotherapy Sensitivity in Leukaemia Patients | 11.2 | 0 | 1 |
| Cytotoxic Compounds Isolated from Murraya tetramera Huang | 11.2 | 0 | 1 |
| Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene | 11.2 | 0 | 1 |
| Detection of PI3K Inhibition in Human Neuroblastoma Using Multiplex Luminex Bead Immunoassay: A Targeted Approach for Pathway Analysis | 11.2 | 0 | 1 |
| A spatiotemporally defined in vitro microenvironment for controllable signal delivery and drug screening. | 11.2 | 0 | 1 |
| Using zebrafish models of leukemia to streamline drug screening and discovery | 11.2 | 0 | 1 |
| Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma | 11.2 | 0 | 1 |
| Development of Basal-Like HaCaT Keratinocytes Containing the Genome of Human Papillomavirus (HPV) Type 11 for Screening of Anti-HPV Effects | 11.2 | 0 | 1 |
| Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening | 11.2 | 0 | 1 |
| A microfluidic-based platform for tumour spheroid culture, monitoring and drug screening | 11.2 | 0 | 1 |
| Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study | 11.2 | 0 | 1 |
| Culture Dimensionality Influences the Resistance of Glioblastoma Stem-like Cells to Multikinase Inhibitors | 11.2 | 0 | 1 |
| Real-time investigation of human topoisomerase I reaction kinetics using an optical sensor: a fast method for drug screening and determination of active enzyme concentrations | 11.2 | 0 | 1 |
| Vertebrate embryos as tools for anti-angiogenic drug screening and function. | 11.2 | 0 | 1 |
| Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening | 11.2 | 0 | 1 |
| Development of a novel multi-layer microfluidic device towards characterization of drug metabolism and cytotoxicity for drug screening | 11.2 | 0 | 1 |
| A hydrophobic residue in position 15 of the rP2X3 receptor slows desensitization and reveals properties beneficial for pharmacological analysis and high-throughput screening | 11.2 | 0 | 1 |
| Silicate fiber-based 3D cell culture system for anticancer drug screening | 11.2 | 0 | 1 |
| Review of "Introducing Technical Skills Assessment Into Certification: Closing the Implementation Gap" by Arora S, Darzi A in Ann Surg 264:7-9, 2016. | 11.2 | 0 | 1 |
| Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening | 11.2 | 0 | 1 |
| Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression | 11.2 | 0 | 1 |
| Cell culture monitoring for drug screening and cancer research: a transparent, microfluidic, multi-sensor microsystem | 11.2 | 0 | 1 |
| Impact on CDC Guideline Compliance After Incorporating Pharmacy in a Pneumococcal Vaccination Screening Process | 11.2 | 0 | 1 |
| Leishmania amastigotes as targets for drug screening. | 11.2 | 0 | 1 |
| A silk fibroin based hepatocarcinoma model and the assessment of the drug response in hyaluronan-binding protein 1 overexpressed HepG2 cells | 11.2 | 0 | 1 |
| Communicating with patients: skills assessment in US colleges of pharmacy | 11.2 | 0 | 1 |
| Selective metabolic effects of gold nanorods on normal and cancer cells and their application in anticancer drug screening | 11.2 | 0 | 1 |
| Engineered muscle tissues for disease modeling and drug screening applications | 11.2 | 0 | 1 |
| Emergency department alcohol and drug screening for Illinois pediatric trauma patients, 1999 to 2009. | 11.2 | 0 | 1 |
| Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial | 11.2 | 0 | 1 |
| Lab-on-a-Chip for anticancer drug screening using quantum dots probe based apoptosis assay | 11.2 | 0 | 1 |
| Optogenetic methods in drug screening: technologies and applications | 11.2 | 0 | 1 |
| Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine | 11.2 | 0 | 1 |
| A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterization. | 11.2 | 0 | 1 |
| The impact of humanitarian context conditions and individual characteristics on aid worker retention | 11.2 | 0 | 1 |
| Multiple Locations of Nerve Compression: An Unusual Cause of Persistent Lower Limb Paresthesia | 11.2 | 0 | 1 |
| The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer. | 11.2 | 0 | 1 |
| Rank classification based on the combination of indocyanine green retention rate at 15 min and 99mTc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection | 11.2 | 0 | 1 |
| Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening | 11.2 | 0 | 1 |
| Pacific Partnership 2008: the surgical mission, surgical screening process, and the anesthetic management of uncontrolled, untreated hypertensive patients | 11.2 | 0 | 1 |
| In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result | 11.2 | 0 | 1 |
| Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study | 11.2 | 0 | 1 |
| Preemployment drug screening in a large metropolitan medical center: a one-month trial | 11.2 | 0 | 1 |
| Routine Drug Screening for Patients in the Emergency Department of a State Psychiatric Hospital: A Naturalistic Cohort Study | 11.2 | 0 | 1 |
| High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model | 11.2 | 0 | 1 |
| Family, personality, and social risk factors impacting the retention rates of first-year Hispanic and Anglo college students | 11.2 | 0 | 1 |
| Perfusion enhanced polydimethylsiloxane based scaffold cell culturing system for multi-well drug screening platform. | 11.2 | 0 | 1 |
| Drug screening study using glioma stem-like cells | 11.2 | 0 | 1 |
| Development of a Standardized Kalamazoo Communication Skills Assessment Tool for Radiologists: Validation, Multisource Reliability, and Lessons Learned | 11.2 | 0 | 1 |
| A computer system for on-line drug screening | 11.2 | 0 | 1 |
| Establishment of a pancreatic β cell proliferation model in vitro and a platform for diabetes drug screening | 11.2 | 0 | 1 |
| Establishment of a cell-based drug screening model for identifying agonists of human peroxisome proliferator-activated receptor gamma (PPARγ). | 11.2 | 0 | 1 |
| A programmable microfluidic cell array for combinatorial drug screening | 11.2 | 0 | 1 |
| Active lung volume recruitment to preserve vital capacity in Duchenne muscular dystrophy | 11.2 | 0 | 1 |
| Preemployment drug screening at the Johns Hopkins Hospital, 1989 and 1991. | 11.2 | 0 | 1 |
| Preliminary evidence on retention rates of primary care physicians in rural and urban areas. | 11.2 | 0 | 1 |
| Development of a reporter bovine viral diarrhea virus and initial evaluation of its application for high throughput antiviral drug screening | 11.2 | 0 | 1 |
| Primary and Secondary Drug Screening Assays for Friedreich Ataxia | 11.2 | 0 | 1 |
| DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening | 11.2 | 0 | 1 |
| Validation of the UCSD Performance-based Skills Assessment (UPSA) in Hispanics with and without schizophrenia | 11.2 | 0 | 1 |
| Large-scale drug screening against Babesia divergens parasite using a fluorescence-based high-throughput screening assay. | 11.2 | 0 | 1 |
| Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study | 11.2 | 0 | 1 |
| Specialized temp agencies offer billing relief. | 11.2 | 0 | 1 |
| Development of human tumor cell line panels for use in disease-oriented drug screening | 11.2 | 0 | 1 |
| Dielectrophoresis-based cellular microarray chip for anticancer drug screening in perfusion microenvironments. | 11.2 | 0 | 1 |
| Utility of routine drug screening in a psychiatric emergency setting | 11.2 | 0 | 1 |
| The effects of lung volume recruitment on coughing and pulmonary function in patients with ALS. | 11.2 | 0 | 1 |
| Experience With a Drug Screening Program at a School of Pharmacy | 11.2 | 0 | 1 |
| Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort | 11.2 | 0 | 1 |
| Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania | 11.2 | 0 | 1 |
| High-throughput 3-D cell-based proliferation and cytotoxicity assays for drug screening and bioprocess development | 11.2 | 0 | 1 |
| Drug screening in the workplace--scientific and legal issues | 11.2 | 0 | 1 |
| Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version | 11.2 | 0 | 1 |
| Drug screening in hospital clinical laboratories | 11.2 | 0 | 1 |
| Drug screening in the workplace | 11.2 | 0 | 1 |
| A polymer microstructure array for the formation, culturing, and high throughput drug screening of breast cancer spheroids | 11.2 | 0 | 1 |
| Attitudes, perceptions and practice of alcohol and drug screening, brief intervention and referral to treatment: a case study of New York State primary care physicians and non-physician providers | 11.2 | 0 | 1 |
| Employee drug screening: issues to be resolved in implementing a program | 11.2 | 0 | 1 |
| Pharmacokinetics in drug screening | 11.2 | 0 | 1 |
| Non-invasive detection of cellular bioelectricity based on carbon nanotube devices for high-throughput drug screening | 11.2 | 0 | 1 |
| A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells | 11.2 | 0 | 1 |
| Assessment of retention rates and clinical benefits of a community sealant program | 11.2 | 0 | 1 |
| Use of Freund's adjuvant arthritis test in anti-flammatory drug screening in the rat: value of animal selection and preparation at the breeding center | 11.2 | 0 | 1 |
| Knowledge of the cervical cancer screening process among rural and urban illinois women undergoing colposcopy | 11.2 | 0 | 1 |
| Retention rates and benefits of Painless Punctal Plug F(TM) in dry eye patients | 11.2 | 0 | 1 |
| Drug Screening in Cell Cultures | 11.2 | 0 | 1 |
| An axenic amastigote system for drug screening | 11.2 | 0 | 1 |
| Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening | 11.2 | 0 | 1 |
| A general method for the consecutive integration of single copies of a heterologous gene at multiple locations in the Bacillus subtilis chromosome by replacement recombination | 11.2 | 0 | 1 |
| Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: implications for drug resistance and in vitro drug screening models | 11.2 | 0 | 1 |
| Non-technical skills assessment in surgery | 11.2 | 0 | 1 |
| Analysis of nonadherent apoptotic cells by a quantum dots probe in a microfluidic device for drug screening | 11.2 | 0 | 1 |
| Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening | 11.2 | 0 | 1 |
| Community Living Skills Assessment Inventory: An Instrument to Facilitate Deinstitutionalization of the Severely Developmentally Disabled | 11.2 | 0 | 1 |
| Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models | 11.2 | 0 | 1 |
| Alcohol and drug screening of newborns: would women consent? | 11.2 | 0 | 1 |
| ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice | 11.2 | 0 | 1 |
| Technology skills assessment for deaf and hard of hearing students in secondary school | 11.2 | 0 | 1 |
| Relationship between Housing Status and Retention Rates among HIV-Positive African Americans Enrolled in a Comprehensive Care Program | 11.2 | 0 | 1 |
| Drug screening of neuroprotective agents on an organotypic-based model of spinal cord excitotoxic damage | 11.2 | 0 | 1 |
| Comparative behavioral effects of dibutyryl cyclic AMP and prostaglandin E1 in mice | 11.2 | 0 | 1 |
| Drug Screening | 11.2 | 0 | 1 |
| A Rapid Medical Screening Process Improves Emergency Department Patient Flow During Surge Associated With Novel H1N1 Influenza Virus | 11.2 | 0 | 1 |
| Opening the black box of clinical skills assessment via observation: a conceptual model | 11.2 | 0 | 1 |
| A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: are they an appropriate tool for drug screening? | 11.2 | 0 | 1 |
| A near-infrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination | 11.2 | 0 | 1 |
| Tissue Dynamics Spectroscopy for Three-Dimensional Tissue-Based Drug Screening | 11.2 | 0 | 1 |
| Do role-players affect the outcome of a high-stakes postgraduate OSCE, in terms of candidate sex or ethnicity? Results from an analysis of the 52,702 anonymised case scores from one year of the MRCGP clinical skills assessment | 11.2 | 0 | 1 |
| The relationship between performance on a medical school's clinical skills assessment and USMLE Step 2 CS. | 11.2 | 0 | 1 |
| An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening | 11.2 | 0 | 1 |
| Malmö Treatment Referral and Intervention Study-High 12-Month Retention Rates in Patients Referred from Syringe Exchange to Methadone or Buprenorphine/Naloxone Treatment. | 11.2 | 0 | 1 |
| Dentists with special interests--towards a flexible workforce to meet oral health needs of the future | 11.2 | 0 | 1 |
| Construction and validation of a surgical skills assessment tool for general surgery residency program | 11.2 | 0 | 1 |
| International medical graduates: a qualitative exploration of factors associated with success in the clinical skills assessment | 11.2 | 0 | 1 |
| Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. | 11.2 | 0 | 1 |
| Simulation-based endovascular skills assessment: the future of credentialing? | 11.2 | 0 | 1 |
| Evaluation of the effect of enamel preparation on retention rate of fissure sealant | 11.2 | 0 | 1 |
| Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study | 11.2 | 0 | 1 |
| High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds | 11.2 | 0 | 1 |
| Establishment of a cell-based drug screening model for identifying down-regulators of Protein Tyrosine Phosphatase 1B expression | 11.2 | 0 | 1 |
| Screening Process Failures for Hepatocellular Carcinoma | 11.2 | 0 | 1 |
| Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences | 11.2 | 0 | 1 |
| Social skills assessment and training for the learning disabled: who's on first and what's on second? Part I. | 11.2 | 0 | 1 |
| Experiences of the screening process and the diagnosis abdominal aortic aneurysm among 65-year-old men from invitation to a 1-year surveillance | 11.2 | 0 | 1 |
| Improving Recruitment and Retention Rates in a Randomized Controlled Trial. | 11.2 | 0 | 1 |
| Hepatic organoids for microfluidic drug screening | 11.2 | 0 | 1 |
| Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening | 11.2 | 0 | 1 |
| Adaptation and optimization of a fluorescence-based assay for in vivo antimalarial drug screening. | 11.2 | 0 | 1 |
| HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. | 11.2 | 0 | 1 |
| Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening. | 11.2 | 0 | 1 |
| A high-throughput drug screening system for HIV-1 transcription inhibitors | 11.2 | 0 | 1 |
| Use of human patient simulation and the situation awareness global assessment technique in practical trauma skills assessment | 11.2 | 0 | 1 |
| Comparison of three cell-based drug screening platforms for HSV-1 infection | 11.2 | 0 | 1 |
| Establishment of a cell-based drug screening system for identifying selective down-regulators of mPGES-1. | 11.2 | 0 | 1 |
| Differences Between Japanese and U.S. Children's Performance on “Zoo U”: A Game-Based Social Skills Assessment | 11.2 | 0 | 1 |
| T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication | 11.2 | 0 | 1 |
| Common Sense or Gun Control? Political Communication and News Media Framing of Firearm Sale Background Checks after Newtown | 11.2 | 0 | 1 |
| In vitro assays in preclinical antineoplastic drug screening. | 11.2 | 0 | 1 |
| Impact of Urine Drug Screening on No Shows and Dropouts among Chronic Pain Patients: A Propensity-Matched Cohort Study | 11.2 | 0 | 1 |
| Activators of viral gene expression in polarized epithelial monolayers identified by rapid-throughput drug screening. | 11.2 | 0 | 1 |
| Social rates of return to investment in skills assessment and residency training of international medical graduates in Alberta | 11.2 | 0 | 1 |
| Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective | 11.2 | 0 | 1 |
| Identifying Areas for Improvement in the HIV Screening Process of a High-Prevalence Emergency Department | 11.2 | 0 | 1 |
| Swiss Employment Agency for foreign health care personnel. 19th activity report (for 1977) | 11.2 | 0 | 1 |
| Predictive Value of Positive Drug Screening Results in an Urban Outpatient Population | 11.2 | 0 | 1 |
| Employment agencies for nurses | 11.2 | 0 | 1 |
| Injuries of multiple locations and organs | 11.2 | 0 | 1 |
| Development of a high throughput drug screening assay for the detection of changes in tau levels -- proof of concept with HSP90 inhibitors | 11.2 | 0 | 1 |
| Comparison of Information-Dependent Acquisition on a Tandem Quadrupole TOF vs a Triple Quadrupole Linear Ion Trap Mass Spectrometer for Broad-Spectrum Drug Screening | 11.2 | 0 | 1 |
| The implementation of the clinical skills assessment programme into RPAH | 11.2 | 0 | 1 |
| High performance in silico virtual drug screening on many-core processors. | 11.2 | 0 | 1 |
| Ceramic Hydroxylapatite as a Plaque Growth and Drug Screening Substrate | 11.2 | 0 | 1 |
| Acanthamoeba castellanii: A new high-throughput method for drug screening in vitro | 11.2 | 0 | 1 |
| An automated skills assessment framework for laparoscopic training tasks. | 11.2 | 0 | 1 |
| The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanoma | 11.2 | 0 | 1 |
| The hollow fibre model in cancer drug screening: the NCI experience | 11.2 | 0 | 1 |
| Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening | 11.2 | 0 | 1 |
| The evolution of workplace drug screening: a medical review officer's perspective | 11.2 | 0 | 1 |
| Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis. | 11.2 | 0 | 1 |
| A mechanism-based in vitro anticancer drug screening approach for phenolic phytochemicals | 11.2 | 0 | 1 |
| Drug screening in the athletic setting | 11.2 | 0 | 1 |
| Peer review is an effective screening process to evaluate medical manuscripts | 11.2 | 0 | 1 |
| Yeast as a Model for Studies on Aβ Aggregation Toxicity in Alzheimer's Disease, Autophagic Responses, and Drug Screening. | 11.2 | 0 | 1 |
| Inhibition of return at multiple locations in visual search: When you see it and when you don't | 11.2 | 0 | 1 |
| Retention Rate of Electromagnetic Navigation Bronchoscopic Placed Fiducial Markers for Lung Radiosurgery. | 11.2 | 0 | 1 |
| Replication initiates at multiple locations on an autonomously replicating plasmid in human cells | 11.2 | 0 | 1 |
| HepG2 72-h cytotoxicity assay | 11.2 | 0 | 1 |
| Use of Chlamydomonas reinhardtii mutants for anticancer drug screening | 11.2 | 0 | 1 |
| Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness | 11.2 | 0 | 1 |
| Urine drug screening and the family physician. | 11.2 | 0 | 1 |
| The influence of gender on the communication skills assessment of medical students | 11.2 | 0 | 1 |
| Drug Screening by Enzyme Immunoassay (EMIT) and Thin-Layer Chromatography (Drug Skreen | 11.2 | 0 | 1 |
| Generating an In Vitro 3D Cell Culture Model from Zebrafish Larvae for Heart Research | 11.2 | 0 | 1 |
| Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. | 11.2 | 0 | 1 |
| Developmental issues in social-skills assessment and intervention with children and adolescents | 11.2 | 0 | 1 |
| Achieving partnership: the contribution of nursing education to the production of a flexible workforce | 11.2 | 0 | 1 |
| Punctal Plug Retention Rates for the Treatment of Moderate to Severe Dry Eye: A Randomized, Double-Masked, Controlled Clinical Trial | 11.2 | 0 | 1 |
| Conditionally adherent growth of serum-independent CHO cells for automated drug screening and biopharmaceutical production | 11.2 | 0 | 1 |
| Drug screening by enzyme immunoassay with the American Monitor KDA | 11.2 | 0 | 1 |
| New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening | 11.2 | 0 | 1 |
| The respirophonogram as a means of drug screening (author's transl) | 11.2 | 0 | 1 |
| 3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor | 11.2 | 0 | 1 |
| Multicomponent High-throughput Drug Screening via Inkjet Printing to Verify the Effect of Immunosuppressive Drugs on Immune T Lymphocytes. | 11.2 | 0 | 1 |
| Synergism between inhibitors of Aurora A and KIF11 overcomes KIF15‐dependent drug resistance | 11.2 | 0 | 1 |
| A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening | 11.2 | 0 | 1 |
| Improvement in Clinical Performance of Interns and Residents through Clinical Skills Assessment of the Korean Medical Licensing Examination | 11.2 | 0 | 1 |
| Experience of clinical skills assessment in the Busan-Gyeongnam Consortium | 11.2 | 0 | 1 |
| Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program | 11.2 | 0 | 1 |
| In silico model of the human ClC-Kb chloride channel: pore mapping, biostructural pathology and drug screening | 11.2 | 0 | 1 |
| Anti-Tat MTT assay: a novel anti-HIV drug screening system using the viral regulatory network of replication | 11.2 | 0 | 1 |
| Results of the second Clinical Skills Assessment Examination of the ECFMG. | 11.2 | 0 | 1 |
| Practical clinical skills assessment for a cohort of 680 2nd year human medicine students. Is it feasible? | 11.2 | 0 | 1 |
| Drug screening in biological fluids. The need for a systematic approach. | 11.2 | 0 | 1 |
| Contract staffing: wave of the future? | 11.2 | 0 | 1 |
| Does a Rater's Professional Background Influence Communication Skills Assessment? | 11.2 | 0 | 1 |
| Drug screening of cancer cell lines and human primary tumors using droplet microfluidics. | 11.2 | 0 | 1 |
| Retention rate of zonisamide in intractable epilepsy | 11.2 | 0 | 1 |
| Development of an in vitro drug screening system for Mycobacterium leprae based on the determination of the intrabacterial sodium to potassium ratio of individual bacterial organisms | 11.2 | 0 | 1 |
| Efficacy of drug screening in forensic autopsy: Retrospective investigation of routine toxicological findings | 11.2 | 0 | 1 |
| Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening. | 11.2 | 0 | 1 |
| Propagation of Waldenström's macroglobulinemia cells in vitro and in severe combined immune deficient mice: utility as a preclinical drug screening model. | 11.2 | 0 | 1 |
| Energy-Based Metrics for Arthroscopic Skills Assessment. | 11.2 | 0 | 1 |
| Regulation of smooth muscle alpha-actin promoter in ras-transformed cells: usefulness for setting up reporter gene-based assay system for drug screening | 11.2 | 0 | 1 |
| NCI's anticancer drug screening program may not be selecting for clinically active compounds | 11.2 | 0 | 1 |
| Rapid complementation assay for anti-HIV-1 drug screening and analysis of envelope protein function | 11.2 | 0 | 1 |
| Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening | 11.2 | 0 | 1 |
| Towards intelligent anticancer drug screening in the post-genome era? | 11.2 | 0 | 1 |
| A rapid anticancer drug screening assay by [14C] thymidine uptake in cultured human cancer cells | 11.2 | 0 | 1 |
| Investigation of the antimicrobial activity of soy peptides by developing a high throughput drug screening assay. | 11.2 | 0 | 1 |
| Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models | 11.2 | 0 | 1 |
| Effects of a rater training on rating accuracy in a physical examination skills assessment | 11.2 | 0 | 1 |
| Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening | 11.2 | 0 | 1 |
| ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis | 11.2 | 0 | 1 |
| Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment | 11.2 | 0 | 1 |
| Achievement of constitutive fluorescent pLEXSY-egfp Leishmania braziliensis and its application as an alternative method for drug screening in vitro | 11.2 | 0 | 1 |
| Ready for OR or not? Human reader supplements Eyesi scoring in cataract surgical skills assessment | 11.2 | 0 | 1 |
| The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome | 11.2 | 0 | 1 |
| AUTOMATED QUANTIFICATION OF ZEBRAFISH TAIL DEFORMATION FOR HIGH-THROUGHPUT DRUG SCREENING. | 11.2 | 0 | 1 |
| Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations | 11.2 | 0 | 1 |
| An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines | 11.2 | 0 | 1 |
| The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening | 11.2 | 0 | 1 |